NCT/Study#
NCT04067336 /
KO-MEN-001
A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
